Comparison of 201Tl, 99Tcm-MIBI and 131I imaging in the follow-up of patients with well-differentiated thyroid carcinoma

Nuclear Medicine Communications

Volumn 17, Issue 5, 1996, Pages 373-377

  Ugur O ^a   Kostakoglu, L ^a   Caner, B ^a   GUlaldi N C M ^a   Uysal, U ^a   Elahi, N ^a   Erbengi, G ^a   Bejdik, C ^a   GUler N ^a   ozmen M ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201; THYROTROPIN; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; THALLIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; THYROID CARCINOMA; THYROID SCINTISCANNING; ADENOCARCINOMA; BONE TUMOR; COMPARATIVE STUDY; LABORATORY DIAGNOSIS; METASTASIS; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; RECURRENT DISEASE; REPRODUCIBILITY; SCINTISCANNING; THYROID TUMOR; THYROIDECTOMY; VERTEBRA;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; RECURRENCE; REPRODUCIBILITY OF RESULTS; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; THORACIC VERTEBRAE; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0029664780     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199605000-00004     Document Type: Article

References (10)

1. Maxon HR, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrin Metab Ciin North Am 1990; 19: 685-718.
2. Abdel-Dayem HM, Scott AM, Macapinlac HA, El-Gazzar AH, Larson SM. Role of thallium-201 chloride and Tc-99m sestamibi in tumor imaging. In: Freeman LM, ed. Nuclear medicine annual. New York: Raven Press, 1994: 181-234.
3. Hoefnagel CA, Delprat CC, Marcuse HR, de Fijder JJM. Role of thallium-201 total body scintigraphy in follow up of thyroid carcinoma. J Nucl Med 1986; 27: 1854-1857.
4. Brendel AJ, Guyot M, Jeandot R, Lefort G, Manciet G. Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma.J Nucl Med 1988; 29: 1515-1520.
5. Akram I, Hoskinson M, McEwan AJB, Catz Z. Thyroid cancer follow-up comparing iodine-131, thallium-201 and technetium-99m MIBI (abstract). Eur J Nucl Med 1994; 21: S25.
6. Iida Y, Hidaka A, Hatabu H, Kasagi K, Konishi J. Followup study of postoperative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement.J Nucl Med 1991; 32: 2098-2100.
7. Ramanna L, Waxman A, Braunstein G. Thallium-201 scintigraphy in differentiated thyroid cancer: Comparison with radioiodine scintigraphy and serum thyroglobulin determinations.J Nucl Med 1991; 32: 441-446.
8. Charkes ND, Vitti RA, Brooks K. Thallium-201 SPECT increases detectability of thyroid cancer metastases. J Nucl Med 1990; 31: 147-153.
9. Sundram FX, Goh AS, Ang ES. Role of technetium-99m sestamibi in localization of thyroid cancer metastases. Ann Acad Med Singapore 1993; 22: 560-562.
10. Jeevanram RK, Shah DH, Sharma SM, Ganatra RD. Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients. Nucl Med Biol 1986; 13: 277-279.